Nothing's first pair of headphones now has a concrete launch date
TL;DR Nothing plans to launch its first pair of headphones on July 1.
It will share the same launch day as the Phone 3.
London-based electronics maker Nothing surprised followers last month by revealing it was working on its first pair of headphones. At the time, the company didn't give a launch date, but did say that the product should arrive sometime this summer. Now we know exactly when the company's headphones will drop.
SXSW — an annual music, film, and interactive technologies event that usually takes place in Austin, TX — is in London this week, and Nothing CEO Carl Pei made a quick stop. While on stage, Pei discussed a variety of topics like the future smartphones, AI, and community involvement. In his closing remarks, also shared on his LinkedIn page, the CEO confirmed the launch date of the Nothing Headphone 1.
According to Pei, his company plans to launch the Headphone 1 on July 1. When Nothing first revealed they were working on headphones, there was speculation that they could launch alongside the Phone 3. A couple of days ago, Nothing announced that the Phone 3 would launch on July 1. So it looks like both products are indeed lined up to launch on the same date.
Got a tip? Talk to us! Email our staff at
Email our staff at news@androidauthority.com . You can stay anonymous or get credit for the info, it's your choice.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Goldman Sachs Upgrades Bayer (BAYRY) to Buy
On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock's risk/reward profile appears positive as it approaches H2 2025, with potential catalysts that could drive a re-rating in the medium term. A closeup of pills in a pharmacy, representing the high quality medications of the company. This upgrade follows Bayer's strong operational start to the year, characterized by cost discipline in its Crop Science division and robust momentum in its underlying Pharmaceuticals business. Goldman Sachs suggests that these factors indicate Bayer may have reached the bottom of its negative earnings revision cycle. In key business developments, Bayer's EPS stood at EUR 2.49 in Q1 2025, keeping the company on track to achieve EUR 4.50 to 5.00 at constant currencies for the full year. While sales in the company's Crop Science division declined by 3% due to regulatory impacts affecting higher-margin sales, the Pharmaceuticals segment sales grew by 4% due to an 80% year-over-year increase in Nubeqa and Kerendia sales. Nubeqa is a prostate cancer drug, while Kerendia is used to treat chronic kidney disease associated with type 2 diabetes. The Consumer Health segment sales also increased by 2.5%. Bayer Aktiengesellschaft (OTC:BAYRY) is a global life science company. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. While we acknowledge the potential of BAYRY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Related Content OTC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
These are the 5 most popular Stocks and Shares ISA investments right now!
Investing in a Stocks and Shares ISA continues to be one of the best tax-efficient ways for UK investors to build wealth. But a recurring challenge is deciding which companies to buy shares in. Fortunately, with insights from Hargreaves Lansdown, we can see exactly which stocks are proving to be the most popular. And right now, the top five are: Nvidia Rolls-Royce Holdings Tesla MicroStrategy Glencore (LSE:GLEN) Given these stocks must be popular for a good reason, should investors simply be following the crowd and snapping up shares themselves? Of course not! In the stock market, popularity rarely results in market-beating returns. This is largely because by the time a stock has become popular, most of the unrealised gains have already been baked into the share price. However, that doesn't mean these are necessarily bad businesses. Blindly following the fact is likely going to end in disappointment. However, researching further could reveal interesting opportunities for the future once the hype dies down and a potentially more attractive price emerges. Let's zoom in on Glencore. The mining giant has had quite a rough ride lately, with its share price tumbling by over 40% in the last 12 months. However since April, the stock has finally started slowly moving back in the right direction. This change in attitude comes on the back of the group's first-quarter production report for 2025. While copper production levels have kicked off slowly, management expects this to improve drastically throughout the rest of the year. At the same time, cobalt production – a critical ingredient for lithium-ion batteries – has surged by 44%. And thanks to the group's 2024 Elk Valley Resources acquisition, steelmaking coal production skyrocketed by almost 500%! These gains are being offset by lower production volumes of gold, silver, nickel and, as previously mentioned, copper. However, despite these headwinds, management's reiterated its full-year guidance. Glencore produces critical metals and materials for high-demand technologies such as electric vehicles, data centres, industrial infrastructure, and renewable energy. And this reassertion of targets, along with the stock's low price point, seems to have sparked some early recovery excitement from investors. So much so that analyst consensus is currently projecting a potential 40% share price gain over the next 12 months. However, while this may indeed be a valuable opportunity. There are still some notable risks that investors must consider beyond commodity price fluctuations. ESG investors are hardly fond of management's move to bolster its coal mining operations in the takeover of Elk Valley Resources, opening the door to reputational risk. At the same time, China remains one of Glencore's key customer markets. Should the tariff dispute between the US and China continue, a resulting economic slowdown (particularly in electronics) could adversely impact Glencore's revenue and earnings. The latter risk seems to be the biggest threat right now, in my opinion. And while investing early during a recovery story can be lucrative, it's possible we haven't seen the bottom yet. Therefore, while international trade disputes between the US and China continue, this isn't a stock I'm rushing to add to my Stocks and Shares ISA, even though it's seemingly a popular investment right now. As for the other businesses on this list, research and due diligence are critical to understanding both the risks and potential rewards. The post These are the 5 most popular Stocks and Shares ISA investments right now! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Nvidia, Rolls-Royce Plc, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Yahoo
2 hours ago
- Yahoo
Investing £100 in this penny stock could explode to…
Investing in penny stocks is a risky endeavour that not all investors are comfortable pursuing. After all, the vast majority of these tiny enterprises are small for a good reason. But every once in a while, it's possible to uncover a diamond in the rough. And investing early into these businesses can deliver explosive gains in the long run. That might very well be the case for Oxford Metrics (LSE:OMG). The fledgling technology business specialises in motion intelligence used within a variety of industries. That includes motion capture systems in the entertainment sector, as well as machine vision for industrial manufacturing and automation. And it's already being used by some of the biggest businesses in the world, including Johnson & Johnson, Ubisoft, Boeing, Airbus, and even NASA. So how much money could investors potentially make with just a £100 investment today? Demand for machine vision solutions has been steadily rising, particularly within the manufacturing sector. This comes as a result of increased AI-powered quality control investments and the general digitalisation of factories in the pursuit of efficiency and fewer production errors. That's a key tailwind Oxford Metrics' management team intends to capitalise on with its recent expansion into the sector. And according to analysts, this could prove to be an explosive catalyst that may significantly accelerate revenue growth in 2025 and beyond. With that in mind, it's not so surprising to see some lofty share price forecasts for this penny stock. Canaccord Genuity currently has a 100p share price target, while Numis Securities has set its forecast at 140p. Compared to where the shares currently trade, that suggests a potential 70-140% potential gain, transforming a £100 investment into anywhere between £170 and £240 over the next 12 months. In other words, Oxford Metrics might not be a penny stock for much longer. And if it can continue to expand its market share and top line, a 140% potential gain could be just the tip of the iceberg. Despite having promising technology and future growth potential, like most penny stocks Oxford Metrics has several risks investors must consider. Currently, over a third of its revenues stem from the notoriously cyclical entertainment sector. Expanding into manufacturing will help address this sector's concentration risk. However, penetrating a new market's going to be a challenge and certainly won't happen overnight. There's also the competitive landscape to consider. Despite being a niche technology business, the machine vision market is already flooded with rival firms pursuing the same target customers. That puts a lot of pressure on the firm to continuously innovate and stand out from the crowd with superior technology. If it falls behind, clients may start venturing elsewhere. As with all penny stocks, Oxford Metrics is a risky investment. But with an established customer base, rising sales, and positive albeit choppy profits, the company's certainly in a stronger position than most stocks in this segment of the stock market. That's why, despite the risks, Oxford Metrics may be worth a closer look for long-term investors. The post Investing £100 in this penny stock could explode to… appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Sign in to access your portfolio
